Archives
NF 449 and Platelet P2 Receptor Inhibition
2026-09-16
The 2005 Hechler et al. study established NF 449 as a functionally selective antagonist of platelet P2X1, distinguishing ATP-gated signaling from P2Y1- and P2Y12-mediated pathways. Human platelet assays and mouse thrombosis models showed that dose-dependent P2 receptor inhibition can reduce collagen-triggered activation and thrombus formation, while also revealing important limits to in vivo selectivity.
GLP-1 (9-36) Amide: A Causal Assay Framework
2026-09-15
GLP-1 (9-36) amide can function as a practical perturbation tool for separating GLP-1 receptor signaling from ligand crosstalk. This guide connects receptor pharmacology, cAMP assay design, product handling, and translational interpretation for metabolic regulation studies.
SIS3: Smad3 Inhibitor Workflow Guide
2026-09-15
SIS3 enables selective interrogation of Smad3-dependent TGF-β signaling while preserving Smad2 as a pathway control. This practical guide covers fibrosis research, renal models, reporter assays, and a mechanistic extension into lung adenocarcinoma biology.
Leucomycin’s In Vitro Antibacterial Activity
2026-09-14
Iwata and Akiba’s 1962 study systematically evaluated leucomycin, its A1 fraction, environmental effects, and activity against antibiotic-resistant staphylococci. Its value lies in combining component-level comparison, broth and agar susceptibility methods, clinically derived resistant isolates, and tests of pH and blood effects—an approach that remains useful when designing contemporary macrolide assays.
Anti-HMGB1 Rabbit Monoclonal Antibody Guide
2026-09-14
MA3057 supports research detection of HMGB1 in human, mouse, and rat samples by Western blot, immunohistochemistry, and flow cytometry. It is an unconjugated research reagent that requires assay-specific optimization and should not be used for diagnostic, therapeutic, or other medical applications.
Recombinant Mouse M-CSF: Workflow Guide
2026-09-13
Use tag-free Recombinant Mouse Macrophage Colony Stimulating Factor to standardize mouse macrophage preparation, osteoclast progenitor assays, and disease-relevant functional studies. This guide connects controlled M-CSF exposure with glycolytic, inflammatory, and fibrotic readouts inspired by the IGF2BP1–THBS1–TLR4 pathway.
QX77 Molecular Chaperone Activator Workflow
2026-09-12
QX77 is a research-ready molecular chaperone activator for probing LAMP2A, Rab11, lysosomal trafficking, and ES-cell state transitions. This workflow connects chaperone-mediated autophagy research with the SENP2/HSPA8/FUNDC1 findings reported in bronchopulmonary dysplasia models while clearly separating established evidence from testable extensions.
Reelin–SFK Signaling in Ketamine Antidepressant Action
2026-09-11
The reference study identifies Reelin–Apoer2–Src family kinase signaling as a permissive pathway for ketamine-induced hippocampal synaptic plasticity and antidepressant-like behavioral responses. Its genetic, pharmacological, electrophysiological, and biochemical evidence suggests that impaired baseline NMDA receptor function may contribute to ketamine nonresponsiveness.
PPP1R3G/PP1γ Activate RIPK1-Driven Cell Death
2026-09-11
The reference study identifies PPP1R3G as a regulatory factor that recruits PP1γ to TNFR1 complex I, removing inhibitory phosphorylations from RIPK1 and enabling apoptosis or type I necroptosis. Its genetic, biochemical, and mouse-model evidence defines a phosphatase-controlled checkpoint in inflammatory cell death and provides a framework for separating NF-κB signaling from direct RIPK1 activation.
Irinotecan in Translational DNA-Damage Research
2026-09-10
Irinotecan (CPT-11) is more than a colorectal cancer cytotoxicity tool: it is a schedule-sensitive probe of topoisomerase I–mediated DNA damage. This article connects its SN-38 activation biology with practical assay design and carefully interprets lessons from topotecan research without treating the two agents as interchangeable.
ICOS Signaling and Th2 Differentiation in Allergic Rhinitis
2026-09-10
This study identifies ICOS-expressing Th2 cells as a clinically relevant component of allergic rhinitis, linking their abundance to symptom severity and changes during subcutaneous immunotherapy. Its combination of peripheral-blood immunophenotyping, longitudinal follow-up, and pathway perturbation supports the PI3K-Akt-mTOR axis as a mechanistic connection between ICOS signaling and Th2 differentiation.
Triiodothyronine (T3): Mechanism and Workflows
2026-09-09
Triiodothyronine (T3) is the receptor-active thyroid hormone used to study gene regulation, metabolism, and endocrine signaling in controlled models. This article connects product specifications with receptor biology, assay design, handling, and experimental limits.
Deferasirox Fe3+ chelate: Assay Guide
2026-09-09
A scenario-based guide to using Deferasirox Fe3+ chelate (SKU A3355) in iron-sensitive viability, proliferation, and cytotoxicity workflows. It connects formulation control with recent evidence on mitochondrial ROS, NF-kB signaling, and myeloid differentiation while distinguishing validated product data from practical assay recommendations.
Dacomitinib (PF-00299804) Lab Workflows
2026-09-08
A scenario-based guide to using Dacomitinib (PF-00299804), SKU A8319, in cell viability, proliferation, cytotoxicity, and signaling studies. It connects pan-HER pharmacology with practical stock preparation, assay controls, resistance models, and carefully bounded ferroptosis research applications.
IPA Feedback Control in Auxin Biosynthesis
2026-09-08
The 2022 PNAS study identifies indole-3-pyruvic acid (IPyA, also commonly called IPA) as a negative-feedback regulator of TAA1/TAR aminotransferases in the two-step auxin pathway. Its kinetic and cross-species evidence explains how plants balance IPyA production and consumption to limit inappropriate indole-3-acetic acid formation.
799 records 6/54 page Previous Next First page 上5页 678910 下5页 Last page